Natural Capsules jumps as its arm inaugurates small volume production, R&D blocks
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Natural Capsules is currently trading at Rs. 395.95, up by 9.90 points or 2.56% from its previous closing of Rs. 386.05 on the BSE.
The scrip opened at Rs. 389.90 and has touched a high and low of Rs. 395.95 and Rs. 387.05 respectively. So far 451 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 621.50 on 11-Oct-2022 and a 52 week low of Rs. 336.50 on 05-Jun-2023.
Last one week high and low of the scrip stood at Rs. 403.45 and Rs. 383.05 respectively. The current market cap of the company is Rs. 360.92 crore.
The promoters holding in the company stood at 56.56%, while Institutions and Non-Institutions held 1.31% and 42.13% respectively.
Natural Capsules’ subsidiary -- Natural Biogenex has inaugurated Small Volume Production Block and Research & Development (R&D) Block on September 20, 2023 at Tumkur, Karnataka. The Small Volume Production Block consists of chemical synthesis reactions and clean rooms areas to produce final API (Active pharma ingredients) in small volume batches. This facility consists of Glass Reactor assemble of 200 liters, 100 liters & 50 liters capacity and other process equipment to manufacture Final API, on receipt of relevant drug manufacturing License.
This R&D block consists of CRD (chemical Research & Development),ARD (Analytical Research & Development) section and is equipped with state of art instruments like LCMS, HPLC, GC, FTIR, UV Spectrophotometer etc.
Natural Capsules is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.
